Cargando…
Enhancement of in vitro prostaglandin E2 production by mouse fibrosarcoma cells after co-culture with various anti-tumour effector cells.
We have previously reported that an increase in the production of immunosuppressive prostaglandin E2 by a QR tumour (QR-32) is accompanied by progressive growth of the tumour in syngeneic C57BL/6 mice. In order to determine what kinds of cell and factor(s) enable QR-32 cells to promote PGE2 producti...
Autores principales: | Okada, F., Hosokawa, M., Hasegawa, J., Kuramitsu, Y., Nakai, K., Yuan, L., Lao, H., Kobayashi, H., Takeichi, N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033504/ https://www.ncbi.nlm.nih.gov/pubmed/8054271 |
Ejemplares similares
-
Malignant progression of a mouse fibrosarcoma by host cells reactive to a foreign body (gelatin sponge).
por: Okada, F., et al.
Publicado: (1992) -
Progression of a Weakly Tumorigenic Mouse Fibrosarcoma at the Site of Early Phase of Inflammation Caused by Plastic Plates
por: Okada, Futoshi, et al.
Publicado: (1993) -
Inflammatory cell-mediated tumour progression and minisatellite mutation correlate with the decrease of antioxidative enzymes in murine fibrosarcoma cells
por: Okada, F, et al.
Publicado: (1999) -
Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase
por: Okada, F, et al.
Publicado: (2006) -
EVIDENCE THAT THE BONE RESORPTION-STIMULATING FACTOR PRODUCED BY MOUSE FIBROSARCOMA CELLS IS PROSTAGLANDIN E(2)
: A NEW MODEL FOR THE HYPERCALCEMIA OF CANCER
por: Tashjian, Armen H., et al.
Publicado: (1972)